Rituximab Use in Pediatric Central Demyelinating Disease
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology,Developmental Neuroscience,Neurology,Pediatrics, Perinatology, and Child Health
Reference15 articles.
1. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel;Lennon;J Exp Med,2005
2. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis;Duddy;J Immunol,2007
3. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder;Kim;JAMA Neurology,2013
4. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients;Jacob;Arch Neurol,2008
5. Impact of rituximab on relapse rate and disability in neuromyelitis optica;Bedi;Mult Scler,2011
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review;Multiple Sclerosis and Related Disorders;2024-11
2. B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease;Current Neurology and Neuroscience Reports;2024-09-11
3. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab;Multiple Sclerosis and Related Disorders;2024-07
4. Rituximab treatment in pediatric‐onset multiple sclerosis;European Journal of Neurology;2024-02-20
5. Pediatric Multiple Sclerosis: Clinical Presentation, Diagnosis and Management;Reference Module in Neuroscience and Biobehavioral Psychology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3